Results 241 to 250 of about 32,742 (288)
Some of the next articles are maybe not open access.
2014
Allergic eye disease is a bilateral immune-mediated process of the ocular surface that occurs in up to 25 % of the population of developed countries. Four entities are described as having at least in part some portion of their pathogenesis emanating from mast cell activation: seasonal allergic conjunctivitis (SAC), atopic keratoconjunctivitis (AKC ...
Neal P. Barney, Scott T. Bauer
openaire +1 more source
Allergic eye disease is a bilateral immune-mediated process of the ocular surface that occurs in up to 25 % of the population of developed countries. Four entities are described as having at least in part some portion of their pathogenesis emanating from mast cell activation: seasonal allergic conjunctivitis (SAC), atopic keratoconjunctivitis (AKC ...
Neal P. Barney, Scott T. Bauer
openaire +1 more source
Therapeutic Targets in Allergic Eye Disease
Allergy and Asthma Proceedings, 2001The objective of this article is to provide an overview of the present state of treatment of ocular allergy. Immuno-ophthalmology arose in the portion of this past century when investigators uncovered the uniqueness of the lens proteins and that it could induce an immunological response otherwise know as phacoanaphylaxis.
openaire +2 more sources
Allergic eye disease – a clinical challenge
Clinical & Experimental Allergy, 1998Currently, six basic allergic eye diseases are recognized. In seasonal (SAC) and perennial allergic conjunctivitis (PAC), the allergic response is mediated predominantly by mast cells, whereas the more severe conditions, vernal (VKC) and atopic keratoconjunctivitis (AKC) and giant papillary conjunctivitis (GPC), are associated with a preponderance of T
openaire +2 more sources
The management of allergic eye diseases in primary eye care
Contact Lens and Anterior Eye, 2009Allergy is an over-reaction of the body's immune system to innocuous foreign substances or allergens that the body perceives as a potential threat or undesirable. It is estimated to affect approximately 20% of the population. Of this subset at least 20% suffer from ocular allergy.
openaire +2 more sources
Topical immunomodulators in the management of allergic eye diseases
Current Opinion in Allergy & Clinical Immunology, 2014Allergic eye diseases comprise a spectrum of diseases, with each condition being characterized by a complex immunopathology. The more severe and chronic conditions, such as vernal keratoconjunctivitis and atopic keratoconjunctivitis, involve predominantly mast cells and eosinophils, while also being associated with a preponderance of T cells. Treatment
Nir, Erdinest, Abraham, Solomon
openaire +2 more sources
Allergic- and Immunologic-Mediated Diseases of the Eye and Adnexae
Veterinary Clinics of North America: Small Animal Practice, 1994Significant allergic- and immunologic-mediated diseases of the eye are reviewed. Included are diseases of the lacrimal gland namely keratoconjunctivitis sicca, immune-mediated diseases of the conjunctiva, atopic blepharoconjunctivitis, and marginal blepharitis, uveitis including lens-induced uveitis, episcleritis, orbital cellulitis, and optic neuritis.
openaire +2 more sources
The Role of Eyelash Dyes in Allergic Eye Diseases
Tropical Doctor, 2004A case-control study was carried out on 544 patients who attended our out-patient eye clinic from 1998 to 2002 to determine the role of eyelash dye in allergic eye diseases. There were 272 cases who had allergic eye disease and 272 controls who were patients with no allergic eye disease.
openaire +2 more sources